Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.（CDTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CDTX · 截至 2026年6月8日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
2
近12个月
买卖比
1.50
Buy/Sell (by trades)
整体情绪
Cidara Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
CDTX 季度内部人买卖趋势
CDTX 内幕交易卖出 · CDTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · CDTX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CDTX 高管卖出股份 · CDTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jan 7, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Option | 1,286,786 | $129 | Form 4 |
| Jan 7, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Other | 4,652,309 | $1.03B⚡ | Form 4 |
| Jan 7, 2026 | Bassler Bonnie L Director | Other | 15 | $3K | Form 4 |
| Jan 7, 2026 | Mineo Chrysa Director | Other | 3,320 | $735K | Form 4 |
| Jan 7, 2026 | BURGESS DANIEL D Director | Other | 150 | $33K | Form 4 |
| Jan 7, 2026 | Stein Jeffrey President & CEO · Director | Other | 67,498 | $14.95M⚡ | Form 4 |
| Jan 7, 2026 | KARBE FRANK CFO | Other | 7,526 | $1.67M⚡ | Form 4 |
| Jan 7, 2026 | KARBE FRANK CFO | Other | 43,125 | $9.55M⚡ | Form 4 |
| Jan 7, 2026 | Ward Shane COO & CLO | Other | 25,083 | $5.56M⚡ | Form 4 |
| Jan 7, 2026 | Davarpanah Nicole Negar Chief Medical Officer | Other | 12,553 | $2.78M⚡ | Form 4 |
| Jan 7, 2026 | Davarpanah Nicole Negar Chief Medical Officer | Other | 8,333 | $1.85M⚡ | Form 4 |
| Nov 10, 2020 | Stein Jeffrey President & CEO · Director | Purchase | 2,500 | $100K | Form 4 |
| Dec 31, 2021 | Stein Jeffrey President & CEO · Director | Gift | 1,873 | — | Form 4 |
| Sep 12, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 367 | $50K | Form 4 |
| Jun 5, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 750 | $89K | Form 4 |
| Mar 31, 2017 | Stein Jeffrey President & CEO · Director | Purchase | 645 | $100K | Form 4 |
| May 23, 2016 | Stein Jeffrey President & CEO · Director | Other | 270 | — | Form 4 |
| Mar 31, 2017 | Stein Jeffrey President & CEO · Director | Other | 645 | $100K | Form 4 |
| Jun 5, 2017 | Stein Jeffrey President & CEO · Director | Other | 750 | $89K | Form 4 |
| Sep 12, 2017 | Stein Jeffrey President & CEO · Director | Other | 367 | $50K | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
Director
日期
Jan 7
股数
4,652,309
均价
$221.50
总金额
$1.03B ⚡
Stein Jeffrey
President & CEO · Director
日期
Jan 7
股数
67,498
均价
$221.50
总金额
$14.95M ⚡
Davarpanah Nicole Negar
Chief Medical Officer
日期
Jan 7
股数
12,553
均价
$221.50
总金额
$2.78M ⚡
Davarpanah Nicole Negar
Chief Medical Officer
日期
Jan 7
股数
8,333
均价
$221.50
总金额
$1.85M ⚡
Stein Jeffrey
President & CEO · Director
日期
Nov 10
股数
2,500
均价
$40.01
总金额
$100K
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CDTX 内幕交易
CDTX 内幕交易
Cidara Therapeutics, Inc.（CDTX）内幕交易数据来源于公司内部人（包括RA CAPITAL MANAGEMENT, L.P. (Director), KARBE FRANK (CFO), Davarpanah Nicole Negar (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CDTX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cidara Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CDTX 内幕交易 · 5个问题Cidara Therapeutics, Inc.（CDTX）的内部人包括高管和董事，如RA CAPITAL MANAGEMENT, L.P. (Director), KARBE FRANK (CFO), Davarpanah Nicole Negar (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026